We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.92B
AUM Growth
+$705M
Cap. Flow
+$556M
Cap. Flow %
11.29%
Top 10 Hldgs %
30.88%
Holding
109
New
27
Increased
28
Reduced
31
Closed
16

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$201M
2
VTRS icon
Viatris
VTRS
+$197M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$167M
4
ELV icon
Elevance Health
ELV
+$92.3M
5
THC icon
Tenet Healthcare
THC
+$70.7M

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$84.6M
2
NOW icon
ServiceNow
NOW
+$80.6M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$73.7M
4
CI icon
Cigna
CI
+$60.3M
5
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 59.98%
2 Technology 11.1%
3 Communication Services 4.51%
4 Financials 2.87%
5 Consumer Discretionary 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZAYO
101
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-1,318,879
Closed -$48.5M
JUNO
102
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-1,850,820
Closed -$84.6M
1 2 3 4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q1 2018 Portfolio in Review

As of Q1 2018, PFM Health Sciences held 109 positions worth $4.92B, up 17% from $4.22B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences deployed $556M of net new capital in Q1 2018, opening 27 new positions and adding to 28 existing holdings. Its largest new stake was Bristol-Myers Squibb: 3,123,145 shares worth $198M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 48% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $80.6M trimmed.

  • PFM Health Sciences's largest Q1 2018 buy was Bristol-Myers Squibb: 3,123,145 shares worth $198M.
  • PFM Health Sciences added most to Elevance Health in Q1 2018, an estimated $92.3M increase.
  • PFM Health Sciences's biggest Q1 2018 reduction was ServiceNow, cutting an estimated $80.6M.
  • PFM Health Sciences fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $84.6M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $4.92B portfolio in Q1 2018.
  • PFM Health Sciences opened 27 new positions and closed 16 in Q1 2018.
  • PFM Health Sciences's portfolio value rose 17% quarter-over-quarter to $4.92B.

Based on PFM Health Sciences's 13F filing for Q1 2018, filed 15 May 2018.